| pubmed-article:1345027 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1345027 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:1345027 | lifeskim:mentions | umls-concept:C0338480 | lld:lifeskim |
| pubmed-article:1345027 | lifeskim:mentions | umls-concept:C0009905 | lld:lifeskim |
| pubmed-article:1345027 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1345027 | pubmed:dateCreated | 1994-6-15 | lld:pubmed |
| pubmed-article:1345027 | pubmed:abstractText | Data in references referring to the relation between atypical or menstrual migraine and the use of oral contraception have been reviewed. The authors own observations are discussed on this subject. Motilium and Voltaren have been successfully used for controlling vascular headache developing as a side-effect of contraceptive tablets. In case of migraine associated with dysmenorrhoea and/or premenstrual tension the management with triphasic hormone proved to be of therapeutic value. The authors call attention to the concurrent high incidence of these latter symptoms and suggest the further analysis of this problem. They collect evidence regarding that in the major part of cases atypical migraine is hormone dependent. | lld:pubmed |
| pubmed-article:1345027 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1345027 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1345027 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1345027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1345027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1345027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1345027 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1345027 | pubmed:issn | 0133-3909 | lld:pubmed |
| pubmed-article:1345027 | pubmed:author | pubmed-author:SzigethyAA | lld:pubmed |
| pubmed-article:1345027 | pubmed:author | pubmed-author:DienesLL | lld:pubmed |
| pubmed-article:1345027 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1345027 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:1345027 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1345027 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1345027 | pubmed:pagination | 185-8 | lld:pubmed |
| pubmed-article:1345027 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:meshHeading | pubmed-meshheading:1345027-... | lld:pubmed |
| pubmed-article:1345027 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1345027 | pubmed:articleTitle | The relation between atypical migraine and multiphasic oral contraceptives. | lld:pubmed |
| pubmed-article:1345027 | pubmed:affiliation | Department of Obstetric and Gynaecology, Municipal Hospital-Outpatient Clinic, Celldömölk, Hungary. | lld:pubmed |
| pubmed-article:1345027 | pubmed:publicationType | Journal Article | lld:pubmed |
